Tackling (CD): current evidences and future directions in the treatment of CD infections.
作者信息
Granata Guido, Petrosillo Nicola
机构信息
Systemic and Immune Depression-Associated Infection Unit, National Institute for Infectious Diseases "L. Spallanzani", IRCCS, 00149, Roma, Italy.
Infectious Disease Service, Fondazione Policlinico Universitario Campus Bio-Medico, 00127, Rome, Italy.
出版信息
Lancet Reg Health Eur. 2024 Dec 11;49:101174. doi: 10.1016/j.lanepe.2024.101174. eCollection 2025 Feb.
Abstract
摘要
相似文献
1
Tackling (CD): current evidences and future directions in the treatment of CD infections.应对（艰难梭菌感染）：艰难梭菌感染治疗的当前证据与未来方向
Lancet Reg Health Eur. 2024 Dec 11;49:101174. doi: 10.1016/j.lanepe.2024.101174. eCollection 2025 Feb.
2
Universal molecular Clostridioides difficile screening and overtreatment in solid organ transplant recipients.普遍的分子梭状芽胞杆菌艰难梭菌筛选和实体器官移植受者的过度治疗。
Transpl Infect Dis. 2020 Oct;22(5):e13375. doi: 10.1111/tid.13375. Epub 2020 Jul 1.
3
Progress on mechanisms of antibiotic resistance in Clostridioides difficile.艰难梭菌抗生素耐药机制的研究进展。
Yi Chuan. 2023 Nov 20;45(11):1028-1038. doi: 10.16288/j.yczz.23-193.
4
A rationally designed antimicrobial peptide from structural and functional insights of translation initiation factor 1.从翻译起始因子 1 的结构和功能角度设计的合理抗菌肽。
Microbiol Spectr. 2024 Mar 5;12(3):e0277323. doi: 10.1128/spectrum.02773-23. Epub 2024 Feb 8.
5
Danish national guideline for the treatment of infection and use of faecal microbiota transplantation (FMT).丹麦国家指南： 感染治疗和粪便微生物群移植（FMT）的使用。
Scand J Gastroenterol. 2021 Sep;56(9):1056-1077. doi: 10.1080/00365521.2021.1922749. Epub 2021 Jul 14.
6
A Spore-Forming Probiotic Supplement Improves the Intestinal Immune Response and Protects the Intestinal Health During Recurrent Clostridioides difficile Colonization in Mice.一种孢子形成的益生菌补充剂可改善反复艰难梭菌定植期间小鼠的肠道免疫反应并保护肠道健康。
JPEN J Parenter Enteral Nutr. 2020 Nov;44(8):1428-1438. doi: 10.1002/jpen.1851. Epub 2020 Jun 4.
7
Investigation of the effect of the adsorbent DAV131A on the propensity of moxifloxacin to induce simulated Clostridioides (Clostridium) difficile infection (CDI) in an in vitro human gut model.在体外人体肠道模型中研究吸附剂DAV131A对莫西沙星诱导模拟艰难梭菌感染（CDI）倾向的影响。
J Antimicrob Chemother. 2020 Jun 1;75(6):1458-1465. doi: 10.1093/jac/dkaa062.
8
Clostridioides difficile from Brazilian hospitals: characterization of virulence genes by whole genome sequencing.巴西医院的艰难梭菌：通过全基因组测序对毒力基因进行表征。
Microbes Infect. 2022 Jul-Aug;24(5):104953. doi: 10.1016/j.micinf.2022.104953. Epub 2022 Feb 23.
9
The Effect of Clostridioides difficile Diagnostic Stewardship Interventions on the Diagnosis of Hospital-Onset Clostridioides difficile Infections.艰难梭菌诊断管理干预对医院获得性艰难梭菌感染诊断的影响。
Jt Comm J Qual Patient Saf. 2020 Aug;46(8):457-463. doi: 10.1016/j.jcjq.2020.05.004. Epub 2020 May 21.
10
High Prevalence of Ribotype 176 in the University Hospital in Kosice.科希策大学医院中核糖体分型176的高流行率。
Pathogens. 2023 Mar 8;12(3):430. doi: 10.3390/pathogens12030430.
本文引用的文献
1
Systematic review of the orally administered microbiome therapeutic, fecal microbiota spores, live-brpk, to prevent recurrence of infection in adults.口服微生物群疗法——粪便微生物群孢子（活芽孢）预防成人感染复发的系统评价
SAGE Open Med. 2024 Oct 9;12:20503121241274192. doi: 10.1177/20503121241274192. eCollection 2024.
2
European survey on the current surveillance practices, management guidelines, treatment pathways and heterogeneity of testing of Clostridioides difficile, 2018-2019: results from The Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI).2018 - 2019年欧洲艰难梭菌当前监测实践、管理指南、治疗途径及检测异质性调查：欧洲艰难梭菌感染抗菌耐药性研究（COMBACTE - CDI）结果
J Hosp Infect. 2023 Jan;131:213-220. doi: 10.1016/j.jhin.2022.11.011. Epub 2022 Dec 1.
3
The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey.欧洲粪便微生物群移植（FMT）的应用：一项全欧洲范围的调查。
Lancet Reg Health Eur. 2021 Jul 19;9:100181. doi: 10.1016/j.lanepe.2021.100181. eCollection 2021 Oct.
4
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.欧洲临床微生物学和传染病学会：成人艰难梭菌感染治疗指南的 2021 年更新。
Clin Microbiol Infect. 2021 Dec;27 Suppl 2:S1-S21. doi: 10.1016/j.cmi.2021.09.038. Epub 2021 Oct 20.
5
Trends in U.S. Burden of Infection and Outcomes.美国感染负担和结局的趋势。
N Engl J Med. 2020 Apr 2;382(14):1320-1330. doi: 10.1056/NEJMoa1910215.
6
Multistate point-prevalence survey of health care-associated infections.多州医疗机构相关性感染的时点患病率调查。
N Engl J Med. 2014 Mar 27;370(13):1198-208. doi: 10.1056/NEJMoa1306801.
7
Duodenal infusion of donor feces for recurrent Clostridium difficile.经十二指肠输注供体粪便治疗复发性艰难梭菌感染。
N Engl J Med. 2013 Jan 31;368(5):407-15. doi: 10.1056/NEJMoa1205037. Epub 2013 Jan 16.
8
Toxin-binding treatment for Clostridium difficile: a review including reports of studies with tolevamer.艰难梭菌的毒素结合治疗：一项综述，包括托利瓦默的研究报告
Int J Antimicrob Agents. 2009 Jan;33(1):4-7. doi: 10.1016/j.ijantimicag.2008.07.011. Epub 2008 Sep 18.
Zotero 插件